Bank of America shows 5.2% Outset Medical (OM) stake in 13G filing

Rhea-AI Filing Summary

Bank of America Corporation filed a Schedule 13G reporting a beneficial ownership position in Outset Medical, Inc. common stock. The firm reports holding 950,558 shares, representing 5.2% of the outstanding common stock, based on 18,153,090 shares outstanding as of November 6, 2025.

All voting and dispositive power over these shares is described as shared, with no sole voting or dispositive authority. The filing is made on behalf of Bank of America and several wholly owned subsidiaries, and it states the shares were acquired and are held in the ordinary course of business, not to influence control of Outset Medical.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Outset Medical, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

690145206

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 690145206

1

Names of Reporting Persons

BANK OF AMERICA CORP /DE/

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 0.00
6	Shared Voting Power 950,501.00
7	Sole Dispositive Power 0.00
8	Shared Dispositive Power 950,549.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

950,558.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.2 %

12

Type of Reporting Person (See Instructions)

HC

Comment for Type of Reporting Person: The beneficial ownership calculation relies on the 18,153,090 outstanding shares disclosed in the Form 10-Q by the issuer on November 10, 2025, which reports share totals as of November 6, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Outset Medical, Inc.
(b)	Address of issuer's principal executive offices: 3052 ORCHARD DRIVE, SAN JOSE, CALIFORNIA, 95134.
Item 2.
(a)	Name of person filing: BANK OF AMERICA CORP /DE/
(b)	Address or principal business office or, if none, residence: 100 N TRYON ST CHARLOTTE, NC 28255
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 690145206
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 950,558.00
(b)	Percent of class: 5.2%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 0.00
	(ii) Shared power to vote or to direct the vote: 950,501.00
	(iii) Sole power to dispose or to direct the disposition of: 0.00
	(iv) Shared power to dispose or to direct the disposition of: 950,549.00
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	If a parent holding company has filed this schedule, pursuant to Rule 13d-1(b)(ii)(G), so indicate under Item 3(g) and attach an exhibit stating the identity and the Item 3 classification of the relevant subsidiary. If a parent holding company has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identification of the relevant subsidiary. This statement on Schedule 13G is being filed by Bank of America Corporation on behalf of itself and its wholly owned subsidiaries BofA Securities, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o); Bank of America N.A., a bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c); Merrill Lynch International, a non-U.S. institution in accordance with section 240.13d-1(b)(1)(ii)(J); and Merrill Lynch Pierce Fenner & Smith, Inc., a broker dealer registered under section 15 of the Act (15 U.S.C. 78o).
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

BANK OF AMERICA CORP /DE/

Signature:	/s/ Andres Ortiz
Name/Title:	Authorized Signatory
Date:	02/11/2026

FAQ

What does Bank of America’s Schedule 13G reveal about Outset Medical (OM)?

Bank of America’s Schedule 13G shows it beneficially owns 950,558 shares of Outset Medical common stock, equal to 5.2% of the class. The position is reported as of a triggering event dated December 31, 2025, and is held in the ordinary course of business.

How many Outset Medical shares and what percentage does Bank of America report owning?

Bank of America reports beneficial ownership of 950,558 Outset Medical common shares, representing 5.2% of the outstanding class. The percentage is calculated using 18,153,090 shares outstanding, as disclosed in Outset Medical’s Form 10-Q reporting share totals as of November 6, 2025.

What voting and dispositive powers does Bank of America have over Outset Medical shares?

The filing reports no sole voting or dispositive power over Outset Medical shares. It shows shared voting power over 950,501 shares and shared dispositive power over 950,549 shares, indicating decision-making authority is shared among Bank of America-related entities rather than concentrated solely at the parent company.

Which Bank of America subsidiaries are associated with the Outset Medical position?

The Schedule 13G is filed by Bank of America Corporation on behalf of itself and wholly owned subsidiaries BofA Securities, Inc., Bank of America N.A., Merrill Lynch International, and Merrill Lynch Pierce Fenner & Smith, Inc. These entities include registered broker-dealers, a bank, and a non-U.S. institution.

What does the Schedule 13G say about Bank of America’s intent regarding Outset Medical?

The certification states the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of Outset Medical. It also notes they are not held in connection with any transaction intended to have that control-changing effect.

What reference date and outstanding share count underpin Bank of America’s 5.2% figure?

The 5.2% ownership figure relies on 18,153,090 Outset Medical shares outstanding, as disclosed in the company’s Form 10-Q filed November 10, 2025, which reports share totals as of November 6, 2025. This share count is used to compute Bank of America’s reported ownership percentage.